Bringing light to discovery

 

Explore the Future of Mass Spectrometry

Advances in mass spectrometry are making it easier than ever to explore biology at unprecedented scale and sensitivity. From disease mechanisms to clinical research, scientists are uncovering deeper insights with greater confidence.

 

Leaders in proteomics, metabolomics, biopharma, and translational research are leveraging next-generation Orbitrap technology to push the boundaries of discovery.

 

Explore how these innovative instruments are enabling breakthroughs across a wide range of scientific applications.

 


Orbitraps and the new Orbitrap Astral Zoom for Chemical Exposomics in Human Serum

Join Jonathan Martin, Ph.D., as he demonstrates how the new Thermo ScientificTM OrbitrapTM AstralTM Zoom mass spectrometer is transforming exposome science. Learn how ultra-sensitive detection, enhanced molecular coverage, and improved spectral quality are enabling researchers to uncover thousands of environmental chemicals and metabolites in blood, at concentrations up to 100-fold lower than previously possible. Discover how these advances are unlocking deeper insights into human health, including the impact of “forever chemicals” and other environmental exposures.


The SEISMIC Facility for single and sub-cellular "omics"

Discover how Dr. Melanie Bailey is using live-cell imaging and the Thermo ScientificTM OrbitrapTM ExcedionTM Pro mass spectrometer to unlock single-cell and subcellular metabolomics. Learn how enhanced sensitivity, reproducibility, and MS² coverage are revealing new insights into infection dynamics, host–pathogen interactions, and disease mechanisms at the cellular level.


Faster, deeper and more sensitive: High-throughput proteomics with Thermo Scientific Orbitrap Astral Zoom MS

Join Jesper Olsen, Ph.D., Professor, University of Copenhagen, Denmark, as he showcases how the new Thermo ScientificTM OrbitrapTM AstralTM Zoom mass spectrometer is transforming high-throughput proteomics. Discover how ultra-fast acquisition, enhanced dynamic range, and low-input modes are unlocking deep, reproducible insights from single cells and clinical samples, including cerebrospinal fluid from pediatric leukemia patients.


Expanding biopharma characterization capability using the Orbitrap Excedion Pro BioPharma Hybrid MS

Jonathan Bones, Ph.D., Principal Investigator and Director of CONCEPT, NIBRT, showcases how advanced fragmentation techniques (ETD, EThcD), a soft-ionization front end, and extended mass-range capabilities of the Thermo ScientificTM OrbitrapTM ExcedionTM Pro mass spectrometer enable deep structural analysis of complex biotherapeutics. Explore practical workflows for glycosylation mapping, disulfide bond characterization, and side-by-side comparisons of innovator and biosimilar molecules.


Realize a Universe of Possibilities

Join Christian Hock, Ph.D., Director of R&D Instrument Development at Thermo Fisher Scientific, as he introduces two groundbreaking innovations in Orbitrap technology—the Thermo ScientificTM OrbitrapTM ExcedionTM Pro and the Thermo ScientificTM OrbitrapTM AstralTM Zoom mass spectrometers.
 

These next-generation platforms are designed to push the boundaries of speed, sensitivity, and dynamic range. Explore how these new systems are redefining discovery workflows.

Register now to watch the full presentation.


Register now


To ensure that we are complying with your preferences, we need to confirm your permission to send you communication. Please check the form of communication that you agree for us to contact you:

Additional interest(s) (multiple selections allowed)